In Situ and in Vivo Study of Nasal Absorption of Paeonol in Rats

被引:19
作者
Chen, Xiaolan [1 ,2 ]
Lu, Yang [1 ]
Du, Shouying [1 ]
Xu, Bing [1 ]
Wang, Shan [1 ]
Zhai, Yongsong [1 ]
Song, Xiao [1 ]
Li, Pengyue [1 ]
机构
[1] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing 100102, Peoples R China
[2] Guiyang Coll TCM, Dept Chinese Pharm, Guiyang 550002, Guizhou, Peoples R China
关键词
paeonol; nasal absorption; in situ; single pass perfusion technique; pharmacokinetics; CEREBROSPINAL-FLUID; TRANSPORT;
D O I
10.3390/ijms11124882
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this work was to study the in situ and in vivo nasal absorption of paeonol. A novel single pass in situ nasal perfusion technique was applied to examine the rate and extent of nasal absorption of paeonol by rats. Various experimental conditions, such as perfusion rate, pH, osmotic pressure and drug concentration, were investigated. The in situ experiments showed that the nasal absorption of paeonol was not dependent on drug concentration, and fitted a first order process. The absorption rate constant, Ka, increased with an increase in perfusion speed. Paeonol was better absorbed in acidic solutions than in neutral or alkaline solutions. The value of Ka was higher in a hypertonic environment than under isotonic or hypotonic conditions. In vivo studies of paeonol absorption were carried out in rats and the pharmacokinetics parameters of intranasal (i.n.) and intragastric (i.g.) administration were compared with intravenous (i.v.) administration. The bioavailabilities of paeonol were 52.37% and 15.81% for i.n. and i.g, respectively, while T-max values were 3.05 +/- 1.46 min and 6.30 +/- 0.70 min. MRT (Mean Residence Time) were 23.19 +/- 6.46 min, 41.49 +/- 2.96 min and 23.09 +/- 5.88 min for i.n., i.g. and i.v. methods, respectively. The results demonstrate that paeonol could be absorbed promptly and thoroughly by i.n. administration in rats.
引用
收藏
页码:4882 / 4890
页数:9
相关论文
共 10 条
[1]   Evaluation of brain-targeting for the nasal delivery of ergoloid mesylate by the microdialysis method in rats [J].
Chen, Jian ;
Wang, Xiaomei ;
Wang, Juan ;
Liu, Guangli ;
Tang, Xing .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 68 (03) :694-700
[2]  
Dominique D., 1993, DRUG DEV IND PHARM, V19, P101
[3]   Transport of drugs from the nasal cavity to the central nervous system [J].
Illum, L .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 11 (01) :1-18
[4]   The In Situ and In Vivo Study on Enhancing Effect of Borneol in Nasal Absorption of Geniposide in Rats [J].
Lu, Yang ;
Chen, Xiaolan ;
Du, Shouying ;
Wu, Qing ;
Yao, Zongling ;
Zhai, Yongsong .
ARCHIVES OF PHARMACAL RESEARCH, 2010, 33 (05) :691-696
[5]   TRANSPORT OF CEPHALEXIN TO THE CEREBROSPINAL-FLUID DIRECTLY FROM THE NASAL CAVITY [J].
SAKANE, T ;
AKIZUKI, M ;
YOSHIDA, M ;
YAMASHITA, S ;
NADAI, T ;
HASHIDA, M ;
SEZAKI, H .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1991, 43 (06) :449-451
[6]   DIRECT DRUG TRANSPORT FROM THE RAT NASAL CAVITY TO THE CEREBROSPINAL-FLUID - THE RELATION TO THE DISSOCIATION OF THE DRUG [J].
SAKANE, T ;
AKIZUKI, M ;
YAMASHITA, S ;
SEZAKI, H ;
NADAI, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (05) :378-379
[7]  
Shi Z., 2004, J CHIN PHARM SCI, V13, P32
[8]  
Wang YF, 1998, BIOPHARM DRUG DISPOS, V19, P571, DOI 10.1002/(SICI)1099-081X(199812)19:9<571::AID-BDD142>3.0.CO
[9]  
2-O
[10]  
Zhang G, 1997, Zhong Yao Cai, V20, P626